1
|
Nair PJ, Pfaller MR, Dual SA, McElhinney DB, Ennis DB, Marsden AL. Non-invasive Estimation of Pressure Drop Across Aortic Coarctations: Validation of 0D and 3D Computational Models with In Vivo Measurements. Ann Biomed Eng 2024; 52:1335-1346. [PMID: 38341399 DOI: 10.1007/s10439-024-03457-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2023] [Accepted: 01/20/2024] [Indexed: 02/12/2024]
Abstract
Blood pressure gradient ( Δ P ) across an aortic coarctation (CoA) is an important measurement to diagnose CoA severity and gauge treatment efficacy. Invasive cardiac catheterization is currently the gold-standard method for measuring blood pressure. The objective of this study was to evaluate the accuracy of Δ P estimates derived non-invasively using patient-specific 0D and 3D deformable wall simulations. Medical imaging and routine clinical measurements were used to create patient-specific models of patients with CoA (N = 17). 0D simulations were performed first and used to tune boundary conditions and initialize 3D simulations. Δ P across the CoA estimated using both 0D and 3D simulations were compared to invasive catheter-based pressure measurements for validation. The 0D simulations were extremely efficient ( ∼ 15 s computation time) compared to 3D simulations ( ∼ 30 h computation time on a cluster). However, the 0D Δ P estimates, unsurprisingly, had larger mean errors when compared to catheterization than 3D estimates (12.1 ± 9.9 mmHg vs 5.3 ± 5.4 mmHg). In particular, the 0D model performance degraded in cases where the CoA was adjacent to a bifurcation. The 0D model classified patients with severe CoA requiring intervention (defined as Δ P ≥ 20 mmHg) with 76% accuracy and 3D simulations improved this to 88%. Overall, a combined approach, using 0D models to efficiently tune and launch 3D models, offers the best combination of speed and accuracy for non-invasive classification of CoA severity.
Collapse
Affiliation(s)
- Priya J Nair
- Department of Bioengineering, Stanford University, Stanford, CA, USA
- Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA
| | - Martin R Pfaller
- Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA
- Department of Pediatrics - Cardiology, Stanford University, Stanford, CA, USA
- Maternal and Child Health Research Institute, Stanford University, Stanford, CA, USA
- Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA, USA
| | - Seraina A Dual
- Department of Biomedical Signaling and Health Systems, KTH Royal Institute of Technology, Stockholm, Sweden
| | - Doff B McElhinney
- Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA
- Department of Pediatrics - Cardiology, Stanford University, Stanford, CA, USA
- Maternal and Child Health Research Institute, Stanford University, Stanford, CA, USA
- Department of Cardiothoracic Surgery, Stanford University, Stanford, CA, USA
| | - Daniel B Ennis
- Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA
- Maternal and Child Health Research Institute, Stanford University, Stanford, CA, USA
- Department of Radiology, Stanford University, Stanford, CA, USA
- Division of Radiology, VA Palo Alto Healthcare System, Palo Alto, CA, USA
| | - Alison L Marsden
- Department of Bioengineering, Stanford University, Stanford, CA, USA.
- Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA.
- Department of Pediatrics - Cardiology, Stanford University, Stanford, CA, USA.
- Maternal and Child Health Research Institute, Stanford University, Stanford, CA, USA.
- Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA, USA.
| |
Collapse
|
2
|
Dual SA, Cowger J, Roche E, Nayak A. The Future of Durable Mechanical Circulatory Support: Emerging Technological Innovations and Considerations to Enable Evolution of the Field. J Card Fail 2024; 30:596-609. [PMID: 38431185 DOI: 10.1016/j.cardfail.2024.01.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2023] [Revised: 01/25/2024] [Accepted: 01/26/2024] [Indexed: 03/05/2024]
Abstract
The field of durable mechanical circulatory support (MCS) has undergone an incredible evolution over the past few decades, resulting in significant improvements in longevity and quality of life for patients with advanced heart failure. Despite these successes, substantial opportunities for further improvements remain, including in pump design and ancillary technology, perioperative and postoperative management, and the overall patient experience. Ideally, durable MCS devices would be fully implantable, automatically controlled, and minimize the need for anticoagulation. Reliable and long-term total artificial hearts for biventricular support would be available; and surgical, perioperative, and postoperative management would be informed by the individual patient phenotype along with computational simulations. In this review, we summarize emerging technological innovations in these areas, focusing primarily on innovations in late preclinical or early clinical phases of study. We highlight important considerations that the MCS community of clinicians, engineers, industry partners, and venture capital investors should consider to sustain the evolution of the field.
Collapse
Affiliation(s)
- Seraina A Dual
- KTH Royal Institute of Technology, Department of Biomedical Engineering and Health Systems, Stockholm, Sweden
| | | | - Ellen Roche
- Massachusetts Institute of Technology, Cambridge, Massachusetts
| | - Aditi Nayak
- Baylor University Medical Center, Dallas, Texas.
| |
Collapse
|
3
|
Nair PJ, Pfaller MR, Dual SA, McElhinney DB, Ennis DB, Marsden AL. Non-invasive estimation of pressure drop across aortic coarctations: validation of 0D and 3D computational models with in vivo measurements. medRxiv 2023:2023.09.05.23295066. [PMID: 37732242 PMCID: PMC10508787 DOI: 10.1101/2023.09.05.23295066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/22/2023]
Abstract
Purpose Blood pressure gradient (Δ P ) across an aortic coarctation (CoA) is an important measurement to diagnose CoA severity and gauge treatment efficacy. Invasive cardiac catheterization is currently the gold-standard method for measuring blood pressure. The objective of this study was to evaluate the accuracy of Δ P estimates derived non-invasively using patient-specific 0 D and 3 D deformable wall simulations. Methods Medical imaging and routine clinical measurements were used to create patient-specific models of patients with CoA (N = 17 ). 0 D simulations were performed first and used to tune boundary conditions and initialize 3 D simulations. Δ P across the CoA estimated using both 0 D and 3 D simulations were compared to invasive catheter-based pressure measurements for validation. Results The 0 D simulations were extremely efficient (~15 secs computation time) compared to 3 D simulations (~30 hrs computation time on a cluster). However, the 0 D Δ P estimates, unsurprisingly, had larger mean errors when compared to catheterization than 3 D estimates (12.1 ± 9.9 mmHg vs 5.3 ± 5.4 mmHg). In particular, the 0 D model performance degraded in cases where the CoA was adjacent to a bifurcation. The 0 D model classified patients with severe CoA requiring intervention (defined as Δ P ≥ 20 mmHg) with 76% accuracy and 3 D simulations improved this to 88%. Conclusion Overall, a combined approach, using 0 D models to efficiently tune and launch 3 D models, offers the best combination of speed and accuracy for non-invasive classification of CoA severity.
Collapse
Affiliation(s)
- Priya J. Nair
- Department of Bioengineering, Stanford University, Stanford, CA, USA
| | - Martin R. Pfaller
- Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA
- Department of Pediatrics - Cardiology, Stanford University, Stanford, CA, USA
- Maternal and Child Health Research Institute, Stanford University, Stanford, CA, USA
- Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA, USA
| | - Seraina A. Dual
- Department of Biomedical Signaling and Health Systems, KTH Royal Institute of Technology, Stockholm, Sweden
| | - Doff B. McElhinney
- Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA
- Department of Pediatrics - Cardiology, Stanford University, Stanford, CA, USA
- Maternal and Child Health Research Institute, Stanford University, Stanford, CA, USA
- Department of Cardiothoracic Surgery, Stanford University, Stanford, CA, USA
| | - Daniel B. Ennis
- Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA
- Maternal and Child Health Research Institute, Stanford University, Stanford, CA, USA
- Department of Radiology, Stanford University, Stanford, CA, USA
- Division of Radiology, VA Palo Alto Healthcare System, Palo Alto, CA, USA
| | - Alison L. Marsden
- Department of Bioengineering, Stanford University, Stanford, CA, USA
- Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA
- Department of Pediatrics - Cardiology, Stanford University, Stanford, CA, USA
- Maternal and Child Health Research Institute, Stanford University, Stanford, CA, USA
- Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA, USA
| |
Collapse
|
4
|
Pirozzi I, Kight A, Han AK, Cutkosky MR, Dual SA. Circulatory Support: Artificial Muscles for the Future of Cardiovascular Assist Devices. Adv Mater 2023:e2210713. [PMID: 36827651 DOI: 10.1002/adma.202210713] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/18/2022] [Revised: 02/11/2023] [Indexed: 06/18/2023]
Abstract
Artificial muscles enable the design of soft implantable devices which are poised to transform the way we mechanically support the heart today. Heart failure is a prevalent and deadly disease, which is treated with the implantation of rotary blood pumps as the only alternative to heart transplantation. The clinically used mechanical devices are associated with severe adverse events, which are reflected here in a comprehensive list of critical requirements for soft active devices of the future: low power, no blood contact, pulsatile support, physiological responsiveness, high cycle life, and less-invasive implantation. In this review, we investigate and critically evaluate prior art in artificial muscles for their applicability in the short and long term. We highlight the main challenges regarding the effectiveness, controllability, and implantability of recently proposed actuators and explore future perspectives for attachment, physiological responsiveness, durability, and biodegradability as well as equitable design considerations. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Ileana Pirozzi
- Department of Bioengineering, Stanford University, Palo Alto, 94301, USA
| | - Ali Kight
- Department of Bioengineering, Stanford University, Palo Alto, 94301, USA
| | - Amy Kyungwon Han
- Department of Mechanical Engineering, Seoul National University, Seoul, 08826, South Korea
| | - Mark R Cutkosky
- Department of Mechanical Engineering, Stanford University, Palo Alto, 94301, USA
| | - Seraina A Dual
- Department of Biomedical Engineering, KTH Royal Institute of Technology, 14157, Huddinge, Sweden
| |
Collapse
|
5
|
Kight A, Pirozzi I, Liang X, McElhinney DB, Han AK, Dual SA, Cutkosky M. Decoupling Transmission and Transduction for Improved Durability of Highly Stretchable, Soft Strain Sensing: Applications in Human Health Monitoring. Sensors (Basel) 2023; 23:1955. [PMID: 36850551 PMCID: PMC9967534 DOI: 10.3390/s23041955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/20/2022] [Revised: 01/24/2023] [Accepted: 02/02/2023] [Indexed: 06/18/2023]
Abstract
This work presents a modular approach to the development of strain sensors for large deformations. The proposed method separates the extension and signal transduction mechanisms using a soft, elastomeric transmission and a high-sensitivity microelectromechanical system (MEMS) transducer. By separating the transmission and transduction, they can be optimized independently for application-specific mechanical and electrical performance. This work investigates the potential of this approach for human health monitoring as an implantable cardiac strain sensor for measuring global longitudinal strain (GLS). The durability of the sensor was evaluated by conducting cyclic loading tests over one million cycles, and the results showed negligible drift. To account for hysteresis and frequency-dependent effects, a lumped-parameter model was developed to represent the viscoelastic behavior of the sensor. Multiple model orders were considered and compared using validation and test data sets that mimic physiologically relevant dynamics. Results support the choice of a second-order model, which reduces error by 73% compared to a linear calibration. In addition, we evaluated the suitability of this sensor for the proposed application by demonstrating its ability to operate on compliant, curved surfaces. The effects of friction and boundary conditions are also empirically assessed and discussed.
Collapse
Affiliation(s)
- Ali Kight
- Department of Bioengineering, Stanford University, Stanford, CA 94305, USA
| | - Ileana Pirozzi
- Department of Bioengineering, Stanford University, Stanford, CA 94305, USA
| | - Xinyi Liang
- Department of Mechanical Engineering, Stanford University, Stanford, CA 94305, USA
| | - Doff B. McElhinney
- Department of Cardiology, Lucile Packard Children’s Hospital, Stanford University, Stanford, CA 94305, USA
| | - Amy Kyungwon Han
- Department of Mechanical Engineering, Seoul National University, Seoul 08826, Republic of Korea
| | - Seraina A. Dual
- Department of Biomedical Engineering, KTH Royal Institute of Technology, 11428 Stockholm, Sweden
| | - Mark Cutkosky
- Department of Mechanical Engineering, Stanford University, Stanford, CA 94305, USA
| |
Collapse
|
6
|
Arduini M, Pham J, Marsden AL, Chen IY, Ennis DB, Dual SA. Framework for patient-specific simulation of hemodynamics in heart failure with counterpulsation support. Front Cardiovasc Med 2022; 9:895291. [PMID: 35979018 PMCID: PMC9376255 DOI: 10.3389/fcvm.2022.895291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2022] [Accepted: 07/13/2022] [Indexed: 11/17/2022] Open
Abstract
Despite being responsible for half of heart failure-related hospitalizations, heart failure with preserved ejection fraction (HFpEF) has limited evidence-based treatment options. Currently, a substantial clinical issue is that the disease etiology is very heterogenous with no patient-specific treatment options. Modeling can provide a framework for evaluating alternative treatment strategies. Counterpulsation strategies have the capacity to improve left ventricular diastolic filling by reducing systolic blood pressure and augmenting the diastolic pressure that drives coronary perfusion. Here, we propose a framework for testing the effectiveness of a soft robotic extra-aortic counterpulsation strategy using a patient-specific closed-loop hemodynamic lumped parameter model of a patient with HFpEF. The soft robotic device prototype was characterized experimentally in a physiologically pressurized (50–150 mmHg) soft silicone vessel and modeled as a combination of a pressure source and a capacitance. The patient-specific model was created using open-source software and validated against hemodynamics obtained by imaging of a patient (male, 87 years, HR = 60 bpm) with HFpEF. The impact of actuation timing on the flows and pressures as well as systolic function was analyzed. Good agreement between the patient-specific model and patient data was achieved with relative errors below 5% in all categories except for the diastolic aortic root pressure and the end systolic volume. The most effective reduction in systolic pressure compared to baseline (147 vs. 141 mmHg) was achieved when actuating 350 ms before systole. In this case, flow splits were preserved, and cardiac output was increased (5.17 vs. 5.34 L/min), resulting in increased blood flow to the coronaries (0.15 vs. 0.16 L/min). Both arterial elastance (0.77 vs. 0.74 mmHg/mL) and stroke work (11.8 vs. 10.6 kJ) were decreased compared to baseline, however left atrial pressure increased (11.2 vs. 11.5 mmHg). A higher actuation pressure is associated with higher systolic pressure reduction and slightly higher coronary flow. The soft robotic device prototype achieves reduced systolic pressure, reduced stroke work, slightly increased coronary perfusion, but increased left atrial pressures in HFpEF patients. In future work, the framework could include additional physiological mechanisms, a larger patient cohort with HFpEF, and testing against clinically used devices.
Collapse
Affiliation(s)
- Mattia Arduini
- Department of Radiology, Stanford University, Palo Alto, CA, United States
| | - Jonathan Pham
- Mechanical Engineering, Stanford University, Palo Alto, CA, United States
| | - Alison L. Marsden
- Department of Bioengineering, Stanford University, Palo Alto, CA, United States
- Department of Pediatrics, Stanford University, Palo Alto, CA, United States
| | - Ian Y. Chen
- Cardiovascular Institute, Stanford University, Palo Alto, CA, United States
- Division of Medicine (Cardiology), Veterans Affairs Health Care System, Palo Alto, CA, United States
| | - Daniel B. Ennis
- Department of Radiology, Stanford University, Palo Alto, CA, United States
- Cardiovascular Institute, Stanford University, Palo Alto, CA, United States
- Division of Radiology, Veterans Affairs Health Care System, Palo Alto, CA, United States
| | - Seraina A. Dual
- Department of Radiology, Stanford University, Palo Alto, CA, United States
- Cardiovascular Institute, Stanford University, Palo Alto, CA, United States
- *Correspondence: Seraina A. Dual
| |
Collapse
|
7
|
Dual SA, Verdonk C, Amsallem M, Pham J, Obasohan C, Nataf P, McElhinney DB, Arunamata A, Kuznetsova T, Zamanian R, Feinstein JA, Marsden A, Haddad F. Elucidating tricuspid Doppler signal interpolation and its implication for assessing pulmonary hypertension. Pulm Circ 2022; 12:e12125. [PMID: 36016669 PMCID: PMC9395694 DOI: 10.1002/pul2.12125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/27/2022] [Revised: 07/07/2022] [Accepted: 08/02/2022] [Indexed: 11/06/2022] Open
Abstract
Doppler echocardiography plays a central role in the assessment of pulmonary hypertension (PAH). We aim to improve quality assessment of systolic pulmonary arterial pressure (SPAP) by applying a cubic polynomial interpolation to digitized tricuspid regurgitation (TR) waveforms. Patients with PAH and advanced lung disease were divided into three cohorts: a derivation cohort (n = 44), a validation cohort (n = 71), an outlier cohort (n = 26), and a non-PAH cohort (n = 44). We digitized TR waveforms and analyzed normalized duration, skewness, kurtosis, and first and second derivatives of pressure. Cubic polynomial interpolation was applied to three physiology-driven phases: the isovolumic phase, ejection phase, and "shoulder" point phase. Coefficients of determination and a Bland-Altman analysis was used to assess bias between methods. The cubic polynomial interpolation of the TR waveform correlated strongly with expert read right ventricular systolic pressure (RVSP) with R 2 > 0.910 in the validation cohort. The biases when compared to invasive SPAP measured within 24 h were 6.03 [4.33; 7.73], -2.94 [1.47; 4.41], and -3.11 [-4.52; -1.71] mmHg, for isovolumic, ejection, and shoulder point interpolations, respectively. In the outlier cohort with more than 30% difference between echocardiographic estimates and invasive SPAP, cubic polynomial interpolation significantly reduced underestimation of RVSP. Cubic polynomial interpolation of the TR waveform based on isovolumic or early ejection phase may improve RVSP estimates.
Collapse
Affiliation(s)
- Seraina A. Dual
- Department of Cardiothoracic SurgeryStanford University School of MedicineStanfordCaliforniaUSA
- Cardiovascular InstituteStanford UniversityStanfordCaliforniaUSA
| | - Constance Verdonk
- Department of Medicine, Division of Cardiovascular MedicineStanford University School of MedicineStanfordCaliforniaUSA
- Department of Cardiothoracic SurgeryHospital BichatParisFrance
- INSERM U1148, Cardiovascular BioengineeringParisFrance
| | - Myriam Amsallem
- Cardiovascular InstituteStanford UniversityStanfordCaliforniaUSA
- Department of Medicine, Division of Cardiovascular MedicineStanford University School of MedicineStanfordCaliforniaUSA
- KU Leuven Department of Cardiovascular Sciences, Research Unit Hypertension and Cardiovascular EpidemiologyUniversity of LeuvenLeuvenBelgium
| | - Jonathan Pham
- Department of PediatricsDivision of Pediatric Cardiology, Stanford University School of MedicinePalo AltoCaliforniaUSA
- Department of BioengineeringStanford University School of MedicineStanfordCaliforniaUSA
| | - Courtney Obasohan
- Department of MedicineDivision of Pulmonary and Critical Care Medicine, Stanford University School of MedicineStanfordCaliforniaUSA
| | - Patrick Nataf
- Department of Cardiothoracic SurgeryHospital BichatParisFrance
- INSERM U1148, Cardiovascular BioengineeringParisFrance
| | - Doff B. McElhinney
- Department of Cardiothoracic SurgeryStanford University School of MedicineStanfordCaliforniaUSA
- Cardiovascular InstituteStanford UniversityStanfordCaliforniaUSA
| | - Alisa Arunamata
- Department of PediatricsDivision of Pediatric Cardiology, Stanford University School of MedicinePalo AltoCaliforniaUSA
| | - Tatiana Kuznetsova
- KU Leuven Department of Cardiovascular Sciences, Research Unit Hypertension and Cardiovascular EpidemiologyUniversity of LeuvenLeuvenBelgium
| | - Roham Zamanian
- Department of Mechanical EngineeringStanford UniversityCaliforniaStanfordUSA
- Vera Moulton Wall Center for Pulmonary Vascular Disease at StanfordStanfordCaliforniaUSA
| | - Jeffrey A. Feinstein
- Department of PediatricsDivision of Pediatric Cardiology, Stanford University School of MedicinePalo AltoCaliforniaUSA
- Department of BioengineeringStanford University School of MedicineStanfordCaliforniaUSA
- Department of Mechanical EngineeringStanford UniversityCaliforniaStanfordUSA
| | - Alison Marsden
- Cardiovascular InstituteStanford UniversityStanfordCaliforniaUSA
- Department of PediatricsDivision of Pediatric Cardiology, Stanford University School of MedicinePalo AltoCaliforniaUSA
- Department of BioengineeringStanford University School of MedicineStanfordCaliforniaUSA
- Department of Mechanical EngineeringStanford UniversityCaliforniaStanfordUSA
| | - François Haddad
- Cardiovascular InstituteStanford UniversityStanfordCaliforniaUSA
- Department of Medicine, Division of Cardiovascular MedicineStanford University School of MedicineStanfordCaliforniaUSA
| |
Collapse
|
8
|
Schmid Daners M, Hall S, Sündermann S, Cesarovic N, Kron M, Falk V, Starck C, Meboldt M, Dual SA. Real-Time Ventricular Volume Measured Using the Intracardiac Electromyogram. ASAIO J 2021; 67:1312-1320. [PMID: 33899813 PMCID: PMC8614557 DOI: 10.1097/mat.0000000000001444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Left ventricular end-diastolic volume (EDV) is an important parameter for monitoring patients with left ventricular assist devices (LVADs) and might be useful for automatic LVAD work adaptation. However, continuous information on the EDV is unavailable to date. The depolarization amplitude (DA) of the noncontact intracardiac electromyogram (iEMG) is physically related to the EDV. Here, we show how a left ventricular (LV) volume sensor based on the iEMG might provide beat-wise EDV estimates. The study was performed in six pigs while undergoing a series of controlled changes in hemodynamic states. The LV volume sensor consisted of four conventional pacemaker electrodes measuring the far-field iEMG inside the LV blood pool, using a novel unipolar amplifier. Simultaneously, noninvasive measurements of EDV and hematocrit were recorded. The proposed EDV predictor was tested for statistical significance using a mixed-effect model and associated confidence intervals. A statistically significant (p = 3e-07) negative correlation was confirmed between the DA of the iEMG and the EDV as measured by electric impedance at a slope of -0.069 (-0.089, -0.049) mV/mL. The DA was slightly decreased by increased hematocrit (p = 0.039) and moderately decreased with the opening of the thorax (p = 0.003). The DA of the iEMG proved to be a significant, independent predictor of EDV. The proposed LV volume sensor is simple to integrate into the inflow cannula of an LVAD and thus has the potential to inform the clinician about the state of LV volume in real time and to automatically control the LVAD.
Collapse
Affiliation(s)
| | - Sophie Hall
- From the Product Development Group Zurich, ETH Zurich, Zurich, Switzerland
| | - Simon Sündermann
- DZHK (German Center for Cardiovascular Research), Partner Site Berlin, Berlin, Germany
- Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Cardiovascular Surgery, Berlin, Germany
- German Heart Center Berlin, Department of Cardiothoracic and Vascular Surgery, Berlin, Germany
| | - Nikola Cesarovic
- German Heart Center Berlin, Department of Cardiothoracic and Vascular Surgery, Berlin, Germany
- Division for Surgical Research, University Hospital Zurich and University of Zurich, Zurich, Switzerland
- Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland
| | - Mareike Kron
- Division for Surgical Research, University Hospital Zurich and University of Zurich, Zurich, Switzerland
| | - Volkmar Falk
- DZHK (German Center for Cardiovascular Research), Partner Site Berlin, Berlin, Germany
- Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Cardiovascular Surgery, Berlin, Germany
- German Heart Center Berlin, Department of Cardiothoracic and Vascular Surgery, Berlin, Germany
- Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland
| | - Christoph Starck
- DZHK (German Center for Cardiovascular Research), Partner Site Berlin, Berlin, Germany
- Steinbeis University Berlin, Institute (STI) of Cardiovascular Perfusion, Berlin, Germany
| | - Mirko Meboldt
- From the Product Development Group Zurich, ETH Zurich, Zurich, Switzerland
| | - Seraina A. Dual
- From the Product Development Group Zurich, ETH Zurich, Zurich, Switzerland
- Radiology, Stanford University, Stanford, California
- Cardiovascular Institute, Stanford University, Stanford, California
| |
Collapse
|
9
|
Dual SA, Maforo NG, McElhinney DB, Prosper A, Wu HH, Maskatia S, Renella P, Halnon N, Ennis DB. Right Ventricular Function and T1-Mapping in Boys With Duchenne Muscular Dystrophy. J Magn Reson Imaging 2021; 54:1503-1513. [PMID: 34037289 DOI: 10.1002/jmri.27729] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2021] [Revised: 05/04/2021] [Accepted: 05/05/2021] [Indexed: 01/14/2023] Open
Abstract
BACKGROUND Clinical management of boys with Duchenne muscular dystrophy (DMD) relies on in-depth understanding of cardiac involvement, but right ventricular (RV) structural and functional remodeling remains understudied. PURPOSE To evaluate several analysis methods and identify the most reliable one to measure RV pre- and postcontrast T1 (RV-T1) and to characterize myocardial remodeling in the RV of boys with DMD. STUDY TYPE Prospective. POPULATION Boys with DMD (N = 27) and age-/sex-matched healthy controls (N = 17) from two sites. FIELD STRENGTH/SEQUENCE 3.0 T using balanced steady state free precession, motion-corrected phase sensitive inversion recovery and modified Look-Locker inversion recovery sequences. ASSESSMENT Biventricular mass (Mi), end-diastolic volume (EDVi) and ejection fraction (EF) assessment, tricuspid annular excursion (TAE), late gadolinium enhancement (LGE), pre- and postcontrast myocardial T1 maps. The RV-T1 reliability was assessed by three observers in four different RV regions of interest (ROI) using intraclass correlation (ICC). STATISTICAL TESTS The Wilcoxon rank sum test was used to compare RV-T1 differences between DMD boys with negative LGE(-) or positive LGE(+) and healthy controls. Additionally, correlation of precontrast RV-T1 with functional measures was performed. A P-value <0.05 was considered statistically significant. RESULTS A 1-pixel thick RV circumferential ROI proved most reliable (ICC > 0.91) for assessing RV-T1. Precontrast RV-T1 was significantly higher in boys with DMD compared to controls. Both LGE(-) and LGE(+) boys had significantly elevated precontrast RV-T1 compared to controls (1543 [1489-1597] msec and 1550 [1402-1699] msec vs. 1436 [1399-1473] msec, respectively). Compared to healthy controls, boys with DMD had preserved RVEF (51.8 [9.9]% vs. 54.2 [7.2]%, P = 0.31) and significantly reduced RVMi (29.8 [9.7] g vs. 48.0 [15.7] g), RVEDVi (69.8 [29.7] mL/m2 vs. 89.1 [21.9] mL/m2 ), and TAE (22.0 [3.2] cm vs. 26.0 [4.7] cm). Significant correlations were found between precontrast RV-T1 and RVEF (β = -0.48%/msec) and between LV-T1 and LVEF (β = -0.51%/msec). DATA CONCLUSION Precontrast RV-T1 is elevated in boys with DMD compared to healthy controls and is negatively correlated with RVEF. LEVEL OF EVIDENCE 1 TECHNICAL EFFICACY: Stage 2.
Collapse
Affiliation(s)
- Seraina A Dual
- Department of Radiology, Stanford University, Palo Alto, California, USA.,Department of Cardiothoracic Surgery, Stanford University, Palo Alto, California, USA.,Cardiovascular Institute, Stanford University, Palo Alto, California, USA
| | - Nyasha G Maforo
- Physics and Biology in Medicine Interdepartmental Program, University of California, Los Angeles, California, USA.,Department of Radiological Sciences, University of California, Los Angeles, California, USA
| | - Doff B McElhinney
- Department of Cardiothoracic Surgery, Stanford University, Palo Alto, California, USA
| | - Ashley Prosper
- Department of Radiological Sciences, University of California, Los Angeles, California, USA
| | - Holden H Wu
- Physics and Biology in Medicine Interdepartmental Program, University of California, Los Angeles, California, USA.,Department of Radiological Sciences, University of California, Los Angeles, California, USA
| | - Shiraz Maskatia
- Department of Pediatrics, Stanford University, Palo Alto, California, USA.,Maternal & Child Health Research Institute, Stanford University, Palo Alto, California, USA
| | - Pierangelo Renella
- Department of Radiological Sciences, University of California, Los Angeles, California, USA.,Children's hospital Orange County, University of California, Irvine, California, USA
| | - Nancy Halnon
- Department of Medicine (Cardiology), University of California, Los Angeles, California, USA
| | - Daniel B Ennis
- Department of Radiology, Stanford University, Palo Alto, California, USA.,Cardiovascular Institute, Stanford University, Palo Alto, California, USA.,Maternal & Child Health Research Institute, Stanford University, Palo Alto, California, USA
| |
Collapse
|
10
|
Dual SA, Llerena Zambrano B, Sündermann S, Cesarovic N, Kron M, Magkoutas K, Hengsteler J, Falk V, Starck C, Meboldt M, Vörös J, Schmid Daners M. Continuous Heart Volume Monitoring by Fully Implantable Soft Strain Sensor. Adv Healthc Mater 2020; 9:e2000855. [PMID: 32893478 DOI: 10.1002/adhm.202000855] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Revised: 08/12/2020] [Indexed: 12/11/2022]
Abstract
Cardiothoracic open-heart surgery has revolutionized the treatment of cardiovascular disease, the leading cause of death worldwide. After the surgery, hemodynamic and volume management can be complicated, for example in case of vasoplegia after endocarditis. Timely treatment is crucial for outcomes. Currently, treatment decisions are made based on heart volume, which needs to be measured manually by the clinician each time using ultrasound. Alternatively, implantable sensors offer a real-time window into the dynamic function of our body. Here it is shown that a soft flexible sensor, made with biocompatible materials, implanted on the surface of the heart, can provide continuous information of the heart volume after surgery. The sensor works robustly for a period of two days on a tensile machine. The accuracy of measuring heart volume is improved compared to the clinical gold standard in vivo, with an error of 7.1 mL for the strain sensor versus impedance and 14.0 mL versus ultrasound. Implanting such a sensor would provide essential, continuous information on heart volume in the critical time following the surgery, allowing early identification of complications, facilitating treatment, and hence potentially improving patient outcome.
Collapse
Affiliation(s)
- Seraina A. Dual
- Product Development Group Zurich ETH Zurich Tannenstrasse 3 Zurich 8092 Switzerland
- Cardiothoracic Surgery Stanford University Stanford CA 94305‐5101 USA
| | - Byron Llerena Zambrano
- Laboratory of Biosensors and Bioelectronics ETH Zurich Gloriastrasse 35 Zurich 8092 Switzerland
| | - Simon Sündermann
- DZHK (German Center for Cardiovascular Research) Partner Site Berlin 10785 Berlin Germany
- Department of Cardiovascular Surgery Charité—Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin Germany
- Department of Cardiothoracic and Vascular Surgery German Heart Center Berlin Augustenburger Pl. 1 13353 Berlin Germany
| | - Nikola Cesarovic
- Department of Cardiothoracic and Vascular Surgery German Heart Center Berlin Augustenburger Pl. 1 13353 Berlin Germany
- Department of Health Sciences and Technology Tannenstrasse 3 Zürich 8092 Switzerland
- Division for Surgical Research University Hospital Zurich and University of Zurich Rämistrasse 100 Zürich 8091 Switzerland
| | - Mareike Kron
- Division for Surgical Research University Hospital Zurich and University of Zurich Rämistrasse 100 Zürich 8091 Switzerland
| | | | - Julian Hengsteler
- Laboratory of Biosensors and Bioelectronics ETH Zurich Gloriastrasse 35 Zurich 8092 Switzerland
| | - Volkmar Falk
- DZHK (German Center for Cardiovascular Research) Partner Site Berlin 10785 Berlin Germany
- Department of Cardiovascular Surgery Charité—Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin Germany
- Department of Cardiothoracic and Vascular Surgery German Heart Center Berlin Augustenburger Pl. 1 13353 Berlin Germany
- Department of Health Sciences and Technology Tannenstrasse 3 Zürich 8092 Switzerland
| | - Christoph Starck
- DZHK (German Center for Cardiovascular Research) Partner Site Berlin 10785 Berlin Germany
| | - Mirko Meboldt
- Product Development Group Zurich ETH Zurich Tannenstrasse 3 Zurich 8092 Switzerland
| | - János Vörös
- Laboratory of Biosensors and Bioelectronics ETH Zurich Gloriastrasse 35 Zurich 8092 Switzerland
| | | |
Collapse
|
11
|
Batliner M, Weiss M, Dual SA, Grass B, Meboldt M, Schmid Daners M. Evaluation of a novel flow-controlled syringe infusion pump for precise and continuous drug delivery at low flow rates: a laboratory study. Anaesthesia 2019; 74:1425-1431. [PMID: 31373391 DOI: 10.1111/anae.14784] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/20/2019] [Indexed: 12/25/2022]
Abstract
Syringe infusion pumps are used for the administration of short-acting drugs in anaesthesia and critical care medicine, but are prone to flow irregularities at low flow rates. A flow-controlled syringe infusion pump using an integrated flow sensor for feedback control represents a new approach to overcoming these limitations. This study compares the performance of a prototype flow-controlled syringe pump both at start-up, and during vertical displacement manoeuvres, with that of a standard infusion syringe pump. The novel pump almost completely eliminated delays at start-up and flow irregularities during hydrostatic pressure changes. Related fluctuations in plasma drug concentration were minimised and the known disadvantages of standard syringe infusion pumps currently used in clinical practice were reduced. Besides providing fast start-up to steady-state flow and precise continuous drug delivery at low flow rates during hydrostatic pressure changes, the new pump offers the potential for the development of target-controlled infusion algorithms for short-acting cardiovascular and other drugs.
Collapse
Affiliation(s)
- M Batliner
- Product Development Group Zurich, ETH Zurich, Zurich, Switzerland
| | - M Weiss
- Department of Anaesthesia, University Children's Hospital Zurich, Zurich, Switzerland
| | - S A Dual
- Product Development Group Zurich, ETH Zurich, Zurich, Switzerland
| | - B Grass
- Department of Intensive Care and Neonatology, University Children's Hospital Zurich, Zurich, Switzerland
| | - M Meboldt
- Product Development Group Zurich, ETH Zurich, Zurich, Switzerland
| | - M Schmid Daners
- Product Development Group Zurich, ETH Zurich, Zurich, Switzerland
| |
Collapse
|